Stephanie Graff: What ‘clinically meaningful’ actually means

Stephanie Graff shared on LinkedIn:

“We have all heard the phrase ‘clinically meaningful’ from the podium at a medical conference and either gaffawed or wondered what that actually means?

We sought to find out.

Partnering with key stakeholders including people living with metastatic breast cancer (mBC), caregivers, and health care providers —we interpret ‘clinical meaningfulness’ and ‘clinically meaningful outcomes’ through different eyes and their influence on mBC treatment decision making and care.

Read our manuscript, now published in the Journal of Clinical Oncology – Oncology Practice.”

Source: Stephanie Graff/LinkedIn

Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery

Authors: Stephanie L. Graff, Emily C. Freeman, Meaghan Roach, Rozanne Wilson, Claire Cagle, Sarah Lunsford, Melissa Culhane Maravic, Ricki Fairley, Mary Gullatte, Jeanne Stemland, Paulina Wochal, Julie Katz, Brianna Hoffner, Julie M. Scott, and Suepattra G. May.

Stephanie Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University and co-leader of the Breast Cancer Translational Research Disease Group. She is an Associate Professor of Medicine at the Warren-Alpert School of Medicine. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research, is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times.